Ariad Pharmaceuticals Inc fka ARIA

[bellweather1]

I guess my response to that is, if it runs up to 6.50-7.00 pre rida results, it would suggest the perceived value of rida(in sarcoma) in the price has been significantly reduced.

Therefore, if succeed did then fail, the pullback would be fairly small and very brief in duration(15-25% at most for a matter of hours/days).

I believe it's this view that's taking hold. And I believe it'll continue to bolster both accumulation and share price increases for quite a while(as well as precipitating a more distinctive short squeeze in the near future-upgrades could be the catalyst).

It's sure looking awfully good at 4.51!!!

bw